
Acelyrin 第四季度每股收益为-0.75 美元,超过了-0.99 美元的预期
Acelyrin (NASDAQ:SLRN) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(0.99) by 24.24 percent.

Acelyrin (NASDAQ:SLRN) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(0.99) by 24.24 percent.